Even though biotech has been sky-rocketing over the last five years, the industry's eye-popping growth spurt isn't showing any signs of slowing down. In fact, EvaluatePharma estimates that global prescription drug sales will rise at an astounding compound annual growth rate, or CAGR, of 6.5% until 2022.However, not all biotechs are created equal from a growth standpoint.